From: Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis
Study characteristics | Number of studies (%) |
---|---|
Region of studya | |
 Andean Latin America | 2 (0.5) |
 Central Asia | 3 (0.8) |
 East Asia | 12 (3.1) |
 North Africa & Middle East | 17 (4.4) |
 South Asia | 276 (71) |
 Southeast Asia | 38 (9.8) |
 Sub-Saharan Africa, Central | 6 (1.5) |
 Sub-Saharan Africa, Eastern | 14 (3.6) |
 Sub-Saharan Africa, Western | 21 (5.4) |
Number of blood cultures screened | |
 0-99 | 13 (3.4) |
 100-499 | 43 (11.2) |
 500-999 | 30 (7.8) |
 1000-4999 | 49 (12.8) |
 5000+ | 59 (15.4) |
 Not stated | 190 (49.5) |
Specific age groups | |
 Adults only | 5 (1.3) |
 Children only | 68 (17.7) |
 No specified age restrictions/Adults and children | 311 (81) |
Reported pre-admission antibiotic use (proportion of patients in the study)b | |
 0 | 19 (4.9) |
 1-25% | 15 (3.8) |
 26-50% | 13 (3.3) |
 51-75% | 7 (1.8) |
 76-100% | 7 (1.8) |
 Not stated | 329 (84.4) |
Reported case fatality rate | |
 0 | 61 (15.9) |
 1-5% | 24 (6.3) |
 6-10% | 2 (0.5) |
 11-15% | 1 (0.3) |
 16-20% | 2 (0.5) |
 21-25% | 1 (0.3) |
 Not stated | 293 (76.3) |
Patient typec | |
 Inpatients | 73 (19) |
 Outpatients | 14 (3.6) |
 Outpatients & Emergency department | 6 (1.6) |
 Inpatients & Outpatients | 44 (11.4) |
 Community | 7 (1.8) |
 Not specified | 241 (62.6) |